University of California San Francisco
Give to UCSFWith a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco, and the University of Washington have launched the Weill Neurohub to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.
Adam L. Boxer answers questions about the potential of "basket trials" to accelerate drug development for dementia and neurodegenerative disease.
The net clinical benefit of anticoagulants for atrial fibrillation decreases with age.
UC San Francisco and the Translational Research Institute for Space Health are co-sponsoring the inaugural Space Health Innovation Conference to advance research and scientific understanding of how space travel impacts health.
Now in its sixth year, the Best Global Universities rankings focus on schools’ academic research and reputation.
An algorithm developed by scientists at UC San Francisco and UC Berkeley did better than two out of four expert radiologists at finding tiny brain hemorrhages in head scans—an advance that one day may help doctors treat patients with TBI, strokes and aneurysms.
Research team has detected the immunological remnants of a common seasonal virus in spinal fluid from dozens of patients diagnosed with acute flaccid myelitis (AFM). The findings provide the clearest evidence to date that AFM is caused by an enterovirus (EV) that invades and impairs the central nervous system.